Form 8-K - Current report:
SEC Accession No. 0000950170-23-007414
Filing Date
2023-03-13
Accepted
2023-03-13 06:30:43
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K pstv-20230310.htm   iXBRL 8-K 48892
  Complete submission text file 0000950170-23-007414.txt   165105

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pstv-20230310_lab.xml EX-101.LAB 13360
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pstv-20230310_pre.xml EX-101.PRE 9859
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pstv-20230310.xsd EX-101.SCH 2493
6 EXTRACTED XBRL INSTANCE DOCUMENT pstv-20230310_htm.xml XML 4706
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 23725629
SIC: 3841 Surgical & Medical Instruments & Apparatus